» Articles » PMID: 34757089

Advances in the Treatment, Diagnosis, Control and Scientific Understanding of Taeniid Cestode Parasite Infections over the Past 50 years

Overview
Journal Int J Parasitol
Specialty Parasitology
Date 2021 Nov 10
PMID 34757089
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

In the past 50 years, enormous progress has been made in the diagnosis, treatment and control of taeniid cestode infections/diseases and in the scientific understanding thereof. Most interest in this group of parasites stems from the serious diseases that they cause in humans. It is through this lens that we summarize here the most important breakthroughs that have made a difference to the treatment of human diseases caused by these parasites, reduction in transmission of the taeniid species associated with human disease, or understanding of the parasites' biology likely to impact diagnosis or treatment in the foreseeable future. Key topics discussed are the introduction of anti-cestode drugs, including benzimidazoles and praziquantel, and the development of new imaging modalities that have transformed the diagnosis and post-treatment monitoring of human echinococcoses and neurocysticercosis. The availability of new anti-cestode drugs for use in dogs and a detailed understanding of the transmission dynamics of Echinococcus granulosus sensu lato have underpinned successful programs that have eliminated cystic echinococcosis in some areas of the world and greatly reduced the incidence of infection in others. Despite these successes, cystic and alveolar echinococcosis and neurocysticercosis continue to be prevalent in many parts of the world, requiring new or renewed efforts to prevent the associated taeniid infections. Major advances made in the development of practical vaccines against E. granulosus and Taenia solium will hopefully assist in this endeavour, as might the understanding of the parasites' biology that have come from an elucidation of the nuclear genomes of each of the most important taeniid species causing human diseases.

Citing Articles

Efficacy of a novel chewable tablet (Credelio Quattro) containing lotilaner, moxidectin, praziquantel, and pyrantel for the treatment and control of Echinococcus multilocularis and E. granulosus infections in dogs.

Charles S, Altreuther G, Wang X, Wiseman S, Reinemeyer C, Snyder D Parasit Vectors. 2025; 18(1):99.

PMID: 40065412 PMC: 11895180. DOI: 10.1186/s13071-025-06735-w.


Frontiers in Parasitology Grand Challenge.

Loukas A Front Parasitol. 2025; 1():902098.

PMID: 39816472 PMC: 11731821. DOI: 10.3389/fpara.2022.902098.


Extracts and Terpenoids from Species as Potential Anthelmintics for Neglected Tropical Diseases Caused by Cestode Parasites.

Cevasco Contreras M, Borgo J, Celentano A, Elso O, Bach H, Catalan C Molecules. 2024; 29(18).

PMID: 39339424 PMC: 11433760. DOI: 10.3390/molecules29184430.


Evaluation of the In-Vitro Effects of Albendazole, Mebendazole, and Praziquantel Nanocapsules against Protoscolices of Hydatid Cyst.

Soleymani N, Sadr S, Santucciu C, Rahdar A, Masala G, Borji H Pathogens. 2024; 13(9).

PMID: 39338980 PMC: 11435210. DOI: 10.3390/pathogens13090790.


Anti-echinococcal effect of metformin in advanced experimental cystic echinococcosis: reprogrammed intermediary carbon metabolism in the parasite.

Loos J, Negro P, Ortega H, Salinas F, Aran M, Pellizza L Antimicrob Agents Chemother. 2024; 68(10):e0094124.

PMID: 39264188 PMC: 11459915. DOI: 10.1128/aac.00941-24.